Sandoz Fills Pipeline Gap With Samsung Bioepis’ Ustekinumab

Strikes Deal In Multiple Global Markets For SB17 Biosimilar Rival To Stelara

 
• By David Wallace
  
Hand placing jigsaw puzzle piece into gap
Another piece of Sandoz’s biosimilars portfolio has fallen into place • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business